SGMO

Sangamo Therapeutics, Inc.

0.53 USD
+0.13 (+33.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sangamo Therapeutics, Inc. stock is up 13.68% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 56% of the previous 24 July’s closed higher than June. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
21 Jun 19:37 16 Aug, 2024 0.50 CALL 2000 761
24 Jul 14:28 16 Aug, 2024 0.50 CALL 2000 3820

About Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc. focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection.